Wuhan Zhongyuan Huadian Sci Tech (300018) fair value: what the stock is really worth
As of Sep 22, 2026: fair value of Wuhan Zhongyuan Huadian Sci Tech ¥5.94, price ¥11.99, upside -50.5%, quality 77 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Wuhan Zhongyuan Huadian Sci Tech for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range ¥3.70 – ¥16.10 · fair‑value band ¥4.58 – ¥7.30 · the ¥11.99 price screens above the ¥5.94 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Follow Wuhan Zhongyuan Huadian Sci Tech in your weekly email
Every Wednesday you see whether Wuhan Zhongyuan Huadian Sci Tech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. engages in the smart grid, healthcare, and industrial investment businesses in China.
Show more
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. engages in the smart grid, healthcare, and industrial investment businesses in China. The company offers power system dynamic recording systems, power system time synchronization and measurement systems, smart grid instruments, substation integrated automation systems, distribution network dispatching and integrated automation systems, energy internet system integration, and intelligent equipment; and fault recording waveform, time synchronization, power grid monitoring, information systems, intelligent inspection, power system relay protection testing and distribution network testing equipment, power data recording and analysis equipment, power time measurement and time scale output equipment, and power system integrated testing equipment. It also provides maintenance, commissioning, and operation services for substations and distribution networks, as well as planning, design, consulting, and operation, and maintenance services for the energy internet. In addition, it offers products and services to medical institutions, health administration departments, and individuals; and produces various categories of biochemical in vitro diagnostic reagents and medical testing equipment. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. was founded in 2001 and is headquartered in Wuhan, China.
Stock analysis
Wuhan Zhongyuan Huadian Sci Tech (300018) currently trades at ¥11.99, while our model-based Fair Value estimate is ¥5.94, implying the stock looks roughly 101.9% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ¥3.60 per share, and 0 of the 26 models we run sit above the ¥11.99 price.
Bear case: the Dividend Discount group reads lowest at ¥0.7400, and 26 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: ¥4.58 (bear) to ¥7.30 (bull), the price of ¥11.99 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 77/100 (high quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Wuhan Zhongyuan Huadian Sci Tech reported revenue of 554M CNY in FY2024 versus 406M CNY in FY2020, a compound +8.0%/yr. Reported net income was 77.0M CNY in FY2024, compounding +13.9%/yr from FY2020.
Key figures
Market cap 5.8B CNY (≈ $861M) · P/E ratio 41.3 · P/S ratio 5.75 · EPS (TTM) ¥0.2900 · Dividend yield 0.4% · Net margin 13.9% · Return on equity 10.3% · Return on assets (EBIT) 4.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 45% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −49% fair-value upside, at −50%, 300018 screens richer than that median.
Fair Value models
Bear ¥4.58Fair Value ¥5.94Bull ¥7.30
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (¥0.2900 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.71/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+23.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.6%
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+10.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.9%
Dividend (yield on the price)0.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.10% vs 2%, picking up
Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 17%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+22.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +20.8% a year for the price.
Compare Wuhan Zhongyuan Huadian Sci Tech with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 832 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score77 · Top 25%
Fair Value upside−51% · Below median
Profitability
Return on equity (TTM)10% · Above median
Return on assets6% · Above median
Net margin (TTM)21% · Top 25%
Operating margin (TTM)25% · Top 25%
Growth and dividend
Revenue growth24% · Top 25%
Dividend yield (TTM)0.4% · Bottom 25%
Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper
P/E (TTM)41.3× · Pricier than median
P/B4.48× · Priciest 25%
P/S (TTM)8.50× · Priciest 25%
P/FCF7.4× · Pricier than median
EV/EBITDA36.7× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 22
PAST (return on equity)41· sector 28
HEALTH (low debt)0· sector 95
DIVIDEND (yield)8· sector 24
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Wuhan Zhongyuan Huadian Sci Tech (300018) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of ¥5.94 versus a price of ¥11.99, about −50% upside (overvalued).
What is the fair value of 300018?
Our model-based fair value for Wuhan Zhongyuan Huadian Sci Tech is ¥5.94 (as of Sep 23, 2026), built from audited fundamentals. The current price: ¥11.99.
What is the quality score of 300018?
Wuhan Zhongyuan Huadian Sci Tech has a Quality Score of 77/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wuhan Zhongyuan Huadian Sci Tech (300018)?
Our model-based price target is the fair value of ¥5.94 (as of Sep 23, 2026) from 26 valuation models. Cautious scenario ¥4.58, optimistic scenario ¥7.30. It is a calculation from audited fundamentals, not an analyst target.
What is the Wuhan Zhongyuan Huadian Sci Tech stock forecast for 2026?
Our models put fair value at ¥5.94, about −50% upside versus a price of ¥11.99 (overvalued). Cautious scenario ¥4.58, optimistic scenario ¥7.30. The calculation is refreshed regularly with new filings.
What is the revenue of Wuhan Zhongyuan Huadian Sci Tech (300018)?
Wuhan Zhongyuan Huadian Sci Tech reported trailing-twelve-month revenue of about 679M CNY (latest available figure, as of Sep 23, 2026).
Does Wuhan Zhongyuan Huadian Sci Tech pay a dividend?
Wuhan Zhongyuan Huadian Sci Tech currently shows a dividend yield of about 0.40% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Wuhan Zhongyuan Huadian Sci Tech (300018)?
For today's price to be fair in a discounted-cash-flow model, Wuhan Zhongyuan Huadian Sci Tech would have to grow free cash flow by +22.9 % per year for five years (discount rate 9.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.1 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of 300018 use?
Our models discount Wuhan Zhongyuan Huadian Sci Tech at 9.1 %: a base by market capitalisation (mid), damped by beta 0.50, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Wuhan Zhongyuan Huadian Sci Tech that is +22.9 % per year a year over ten years, using the same discount rate (9.1 %) and the same formula as our fair value.
How much growth has Wuhan Zhongyuan Huadian Sci Tech (300018) delivered so far?
Over the past 5 years revenue at Wuhan Zhongyuan Huadian Sci Tech grew +7.1 % a year. The price currently implies +22.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Wuhan Zhongyuan Huadian Sci Tech (300018) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Wuhan Zhongyuan Huadian Sci Tech (+22.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The free-cash-flow yield on the price is 2.03 %: that much free cash flow Wuhan Zhongyuan Huadian Sci Tech produces per unit of market value. When it exceeds the discount rate of our models (9.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Wuhan Zhongyuan Huadian Sci Tech (300018)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wuhan Zhongyuan Huadian Sci Tech it is ¥5.94 per share (as of Sep 23, 2026), against a price of ¥11.99. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Wuhan Zhongyuan Huadian Sci Tech stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 300018 trades above its calculated fair value: price ¥11.99, fair value ¥5.94, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300018?
No. The price is what the market pays today (¥11.99); the fair value is what the company's own numbers justify (¥5.94). For Wuhan Zhongyuan Huadian Sci Tech the two are ¥6.05 per share apart. That gap is exactly why we show both numbers side by side.
How much is Wuhan Zhongyuan Huadian Sci Tech worth?
The market values Wuhan Zhongyuan Huadian Sci Tech at about 5.8B CNY (market capitalisation, as of Sep 23, 2026). Per share that is ¥11.99; our models calculate a fair value of ¥5.94 per share.
What do the bullish and bearish scenarios say about 300018?
Our models span a range for Wuhan Zhongyuan Huadian Sci Tech: cautious scenario ¥4.58, base ¥5.94, optimistic ¥7.30 per share (as of Sep 23, 2026, price ¥11.99). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 300018?
Wuhan Zhongyuan Huadian Sci Tech trades at a price-to-earnings ratio of 41.3 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥5.94 is built from several models across several years. Other multiples: P/B 4.5, P/S 8.5, EV/EBITDA 36.7.
How solid is the balance sheet of Wuhan Zhongyuan Huadian Sci Tech (300018)?
Balance-sheet figures for Wuhan Zhongyuan Huadian Sci Tech (as of Sep 23, 2026): return on equity 10.3%. They feed the Quality Score of 77/100, which measures business quality independently of the share price.
How far is 300018 from its 52-week high?
Wuhan Zhongyuan Huadian Sci Tech trades at ¥11.99, about 26% below its 52-week high of ¥16.10 and 45% above the low of ¥8.25 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥5.94 is for.
Which stocks are comparable to Wuhan Zhongyuan Huadian Sci Tech?
From the same area (Industrials) we also value GE Vernova Inc, SIE, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wuhan Zhongyuan Huadian Sci Tech stock attractive at the current price?
The data as of Sep 23, 2026: price ¥11.99, calculated fair value ¥5.94 (−50%), Quality Score 77/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300018 calculated?
We run Wuhan Zhongyuan Huadian Sci Tech through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥5.94, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Wuhan Zhongyuan Huadian Sci Tech itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The closing price on Sep 22, 2026 was ¥11.99. Our model-based fair value is ¥5.94, about −50% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wuhan Zhongyuan Huadian Sci Tech right now?
A high-quality business (quality 77/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (¥7.30). The favourable scenario is already priced in.
Where does the earnings growth of Wuhan Zhongyuan Huadian Sci Tech (300018) come from?
Earnings per share at Wuhan Zhongyuan Huadian Sci Tech grew −3.2 % a year from 2013 to 2024. Broken into its drivers: revenue per share +6.2 %, EBIT margin −5.9 %, tax rate −1.5 %, residual (interest, one-offs) −1.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Wuhan Zhongyuan Huadian Sci Tech
How large is the market capitalisation of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The market capitalisation of Wuhan Zhongyuan Huadian Sci Tech is 5.8B CNY (≈ $861M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The price-to-sales ratio of Wuhan Zhongyuan Huadian Sci Tech is 5.75 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Wuhan Zhongyuan Huadian Sci Tech (300018)?
Earnings per share at Wuhan Zhongyuan Huadian Sci Tech are ¥0.2900 (price ÷ EPS = P/E 41.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The dividend yield of Wuhan Zhongyuan Huadian Sci Tech is 0.4% (payout 16.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The net margin of Wuhan Zhongyuan Huadian Sci Tech is 13.9% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The return on equity (ROE) of Wuhan Zhongyuan Huadian Sci Tech is 10.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wuhan Zhongyuan Huadian Sci Tech (300018)?
On an EBIT basis the return on assets of Wuhan Zhongyuan Huadian Sci Tech is 4.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wuhan Zhongyuan Huadian Sci Tech (300018)?
The operating margin of Wuhan Zhongyuan Huadian Sci Tech is 25.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wuhan Zhongyuan Huadian Sci Tech (300018)?
Revenue at Wuhan Zhongyuan Huadian Sci Tech is growing +24.2% versus a year earlier (3y avg +9.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Wuhan Zhongyuan Huadian Sci Tech (300018)?
Earnings per share at Wuhan Zhongyuan Huadian Sci Tech are growing +20.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Wuhan Zhongyuan Huadian Sci Tech (300018) hold?
Wuhan Zhongyuan Huadian Sci Tech holds more cash than debt, 124M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Wuhan Zhongyuan Huadian Sci Tech in the live analysis
One click puts Wuhan Zhongyuan Huadian Sci Tech on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
